EBIT: Income before interest and taxes.
Moderna, Inc. (MRNA) had EBIT of $-907.00M for the most recently reported fiscal quarter, ending 2025-06-30.
Income Statement Financials | |
$142.00M |
|
$-825.00M |
|
$119.00M |
|
$23.00M |
|
$1.05B |
|
$-907.00M |
|
$89.00M |
|
$-818.00M |
|
$-818.00M |
|
$-825.00M |
|
$-825.00M |
|
$-825.00M |
|
$-825.00M |
|
EBIT |
$-907.00M |
$-868.00M |
|
388.00M |
|
388.00M |
|
$-2.13 |
|
$-2.13 |
|
Balance Sheet Financials | |
$6.17B |
|
$2.17B |
|
$5.84B |
|
$12.01B |
|
$1.57B |
|
$32.00M |
|
$1.04B |
|
$2.61B |
|
$9.40B |
|
$9.40B |
|
$9.40B |
|
389.00M |
|
Cash Flow Statement Financials | |
$-1.96B |
|
$1.29B |
|
$13.00M |
|
$1.93B |
|
$1.28B |
|
$-648.00M |
|
$245.00M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
3.93 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
16.20% |
|
-638.73% |
|
-638.73% |
|
-- |
|
-576.06% |
|
-580.99% |
|
$-2.08B |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.50 |
|
3.94 |
|
22.82 |
|
-8.78% |
|
-8.78% |
|
-6.87% |
|
-8.75% |
|
$24.16 |
|
$-5.35 |
|
$-5.04 |